Trademark: 97223954
Word
JERAZGO
Status
Dead
Status Code
606
Status Date
Monday, February 5, 2024
Serial Number
97223954
Mark Type
4000
Filing Date
Tuesday, January 18, 2022
Published for Opposition
Tuesday, May 9, 2023
Abandoned Date
Monday, February 5, 2024

Trademark Owner History
JOHNSON & JOHNSON - Owner At Publication

Classifications
5 Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives

Trademark Events
Feb 5, 2024
Abandonment Notice E-Mailed - No Use Statement Filed
Feb 5, 2024
Abandonment - No Use Statement Filed
Dec 20, 2023
Assignment Of Ownership Not Updated Automatically
Dec 19, 2023
Teas Change Of Correspondence Received
Dec 19, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 19, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 19, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Dec 19, 2023
Teas Change Of Owner Address Received
Jul 4, 2023
Noa E-Mailed - Sou Required From Applicant
May 9, 2023
Official Gazette Publication Confirmation E-Mailed
May 9, 2023
Published For Opposition
Apr 19, 2023
Notification Of Notice Of Publication E-Mailed
Apr 4, 2023
Approved For Pub - Principal Register
Mar 20, 2023
Teas/Email Correspondence Entered
Mar 20, 2023
Correspondence Received In Law Office
Mar 20, 2023
Teas Response To Office Action Received
Sep 22, 2022
Notification Of Non-Final Action E-Mailed
Sep 22, 2022
Non-Final Action E-Mailed
Sep 22, 2022
Non-Final Action Written
Sep 15, 2022
Assigned To Examiner
Jan 24, 2022
New Application Office Supplied Data Entered
Jan 21, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24